A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

NCT06952426 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunoglobulin A Nephropathy

Interventions

OTHER: No intervention
OTHER: Other treatment
OTHER: Iptacopan
OTHER: Atrasentan

Sponsor

Novartis Pharmaceuticals